Nutra Pharma Corp (NPHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 89 | 73 | 135 | 140 | 165 |
| Cost of Goods | 34 | 38 | 41 | 25 | 80 |
| Gross Profit | 55 | 35 | 94 | 115 | 85 |
| Operating Expenses | 308 | 368 | 275 | 306 | 347 |
| Operating Income | -220 | -295 | -140 | -166 | -182 |
| Interest Expense | 87 | 87 | 82 | 85 | 91 |
| Other Income | -61 | -45 | -21 | -28 | -6 |
| Pre-tax Income | -367 | -427 | -243 | -279 | -279 |
| Net Income Continuous | -367 | -427 | -243 | -279 | -279 |
| Net Income | $-367 | $-427 | $-243 | $-279 | $-279 |
| EBITDA(a) | $-162 | $-236 | $-97 | $-114 | $-129 |